Table 2 Performance of PIVKA-II for the diagnosis of AFP-negative HCC patients
AUC(95%CI) | Cutoff value | Sensitivity(%)(95%CI) | Specificity(%)(95%CI) | |
|---|---|---|---|---|
HCC vs Healthy controls | 0.88 (0.82–0.94) | 38.75mAU/ml | 78.33 (66.38–86.88) | 91.3 (85.42–94.96) |
HCC vs Benign liver diseases | 0.76 (0.67–0.85) | 42.07 ng/ml | 74.19 (62.12–83.45) | 82.68 (75.16–88.27) |